Overview

Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the safety and efficacy of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS Plus for use during cataract extraction and intra-ocular lens (IOL) implantation.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Patients any race or sex 18 or older and undergoing cataract extraction with planned
implantation of a posterior chamber intraocular lens.

- Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

- Under 18

- Other protocol-defined exclusion criteria may apply.